In gastric, colon and live cancers, c‐MYC could enhance CCAT1 expression by directly binding to the promoter region of the IncRNA.17, 18 Jiang et al17 reported that TP63 and SOX2 also can bind to the promoter in squamous cell cancers, resulting in induced transcription activity. Here, TP63 is linked to cancer.